↓ Skip to main content

Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia

Overview of attention for article published in Inflammatory Bowel Diseases, February 2013
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia
Published in
Inflammatory Bowel Diseases, February 2013
DOI 10.1097/mib.0b013e318286f771
Pubmed ID
Authors

Fiona D.M. van Schaik, Erik Mooiweer, Mike van der Have, Tim D.G. Belderbos, Fiebo J.W. ten Kate, G. Johan A. Offerhaus, Marguerite E.I. Schipper, Gerard Dijkstra, Marieke Pierik, Pieter C.F. Stokkers, Cyriel Ponsioen, Dirk J. de Jong, Daniel W. Hommes, Ad A. van Bodegraven, Peter D. Siersema, Martijn G.H. van Oijen, Bas Oldenburg

Abstract

It is still unclear whether inflammatory bowel disease (IBD) patients with adenomas have a higher risk of developing high-grade dysplasia (HGD) or colorectal cancer (CRC) than non-IBD patients with sporadic adenomas. We compared the risk of advanced neoplasia (AN, defined as HGD or CRC) in IBD patients with adenomas to IBD patients without adenomas and patients without IBD with adenomas.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 21%
Student > Ph. D. Student 3 16%
Other 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Other 4 21%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 9 47%
Agricultural and Biological Sciences 3 16%
Immunology and Microbiology 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unknown 5 26%